LABORATORIOS FARMACEUTICOS ROVI, S.A. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85.55 EUR | -1.44% |
|
0.00% | +43.00% |
| 02:44pm | Rovi receives non-binding offers for manufacturing business | RE |
| 05-08 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Laboratorios Farmaceuticos Rovi, S.A.
Price target over the last 5 years
History of analyst recommendation changes
a99579f41c0d2f09a7956f0ea953c.nF7s_mAo4Fq41ULJqVKbeh-2JIvL_RG7t-PsgRjzKAQ.yG3YmTp8iBfe7HCh5BmrCX7QRseviVXyxdeh7l2LXGzbC52vNUHTBduRdg~f67f2cc0bf3f511e46a15ba4cf7240d0
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
83
EUR
Average target price
91.31
EUR
Spread / Average Target
+10.02%
High Price Target
100.5
EUR
Spread / Highest target
+21.08%
Low Price Target
83
EUR
Spread / Lowest Target
0.00%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ROVI Stock
- ROVI Stock
- Consensus Laboratorios Farmaceuticos Rovi, S.A.
